Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duncan E Scott

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Natural Product Reports|September 28, 2007
Coenzyme biosynthesis: enzyme mechanism, structure and inhibitionDuncan E Scott, Alessio Ciulli, Chris Abell
Current Opinion in Chemical Biology|March 13, 2010
Drugging challenging targets using fragment-based approachesAnthony G Coyne, Duncan E Scott, Chris Abell
Nature Reviews. Drug Discovery|April 7, 2016
Small molecules, big targets: drug discovery faces the protein-protein interaction challengeDuncan E Scott, Andrew R Bayly, Chris Abell, et al.
Biochemistry|June 16, 2012
Fragment-based approaches in drug discovery and chemical biologyDuncan E Scott, Anthony G Coyne, Sean A Hudson, et al.
Chembiochem : a European Journal of Chemical Biology|October 15, 2009
A fragment-based approach to probing adenosine recognition sites by using dynamic combinatorial chemistryDuncan E Scott, Gwen J Dawes, Michiyo Ando, et al.
FEBS Letters|March 20, 2016
Structure-activity relationship of the peptide binding-motif mediating the BRCA2:RAD51 protein-protein interactionDuncan E Scott, May Marsh, Tom L Blundell, et al.
Nature Reviews. Drug Discovery|September 26, 2024
The benefits of translating biomedical research at drug discovery institutesDavid J Huggins, Jonathan Baell, Paul E Brennan, et al.
Chemmedchem|December 4, 2014
Small-molecule inhibitors that target protein-protein interactions in the RAD51 family of recombinasesDuncan E Scott, Anthony G Coyne, Ashok Venkitaraman, et al.
FEBS Open Bio|July 16, 2016
ATP half-sites in RadA and RAD51 recombinases bind nucleotidesMay E Marsh, Duncan E Scott, Matthias T Ehebauer, et al.
SLAS Discovery : Advancing Life Sciences R & D|July 20, 2025
Overcoming a false-positive mechanism in RapidFire MRM-based high throughput screeningDe Lin, Lesley-Anne Pearson, Shamshad Ahmad, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Natural Product Reports|September 28, 2007
Coenzyme biosynthesis: enzyme mechanism, structure and inhibitionDuncan E Scott, Alessio Ciulli, Chris Abell
Current Opinion in Chemical Biology|March 13, 2010
Drugging challenging targets using fragment-based approachesAnthony G Coyne, Duncan E Scott, Chris Abell
Nature Reviews. Drug Discovery|April 7, 2016
Small molecules, big targets: drug discovery faces the protein-protein interaction challengeDuncan E Scott, Andrew R Bayly, Chris Abell, et al.
Biochemistry|June 16, 2012
Fragment-based approaches in drug discovery and chemical biologyDuncan E Scott, Anthony G Coyne, Sean A Hudson, et al.
Chembiochem : a European Journal of Chemical Biology|October 15, 2009
A fragment-based approach to probing adenosine recognition sites by using dynamic combinatorial chemistryDuncan E Scott, Gwen J Dawes, Michiyo Ando, et al.
FEBS Letters|March 20, 2016
Structure-activity relationship of the peptide binding-motif mediating the BRCA2:RAD51 protein-protein interactionDuncan E Scott, May Marsh, Tom L Blundell, et al.
Nature Reviews. Drug Discovery|September 26, 2024
The benefits of translating biomedical research at drug discovery institutesDavid J Huggins, Jonathan Baell, Paul E Brennan, et al.
Chemmedchem|December 4, 2014
Small-molecule inhibitors that target protein-protein interactions in the RAD51 family of recombinasesDuncan E Scott, Anthony G Coyne, Ashok Venkitaraman, et al.
FEBS Open Bio|July 16, 2016
ATP half-sites in RadA and RAD51 recombinases bind nucleotidesMay E Marsh, Duncan E Scott, Matthias T Ehebauer, et al.
SLAS Discovery : Advancing Life Sciences R & D|July 20, 2025
Overcoming a false-positive mechanism in RapidFire MRM-based high throughput screeningDe Lin, Lesley-Anne Pearson, Shamshad Ahmad, et al.
Pageof 2